Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -350,125 | -165,563 | 39,532 | -263,603 | -149,005 |
| Depreciation Amortization | 277,706 | 311,471 | 157,153 | 43,282 | 13,674 |
| Income taxes - deferred | -132,231 | -65,561 | -180,549 | -7,516 | N/A |
| Accounts receivable | -84,444 | -68,271 | -124,766 | -46,183 | -12,491 |
| Accounts payable and accrued liabilities | -16,521 | 32,065 | -8,362 | 9,383 | 3,908 |
| Other Working Capital | 184,254 | 135,767 | 1,130 | 14,059 | -7,170 |
| Other Operating Activity | 405,701 | 189,548 | 310,028 | 278,127 | 96,797 |
| Operating Cash Flow | $284,340 | $369,456 | $194,166 | $27,549 | $-54,287 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 64,623 | N/A | N/A |
| PPE Investments | -4,336 | -15,725 | -7,156 | -3,500 | -1,198 |
| Net Acquisitions | -97,849 | -1,354,921 | -1,022,361 | -224,220 | -35,000 |
| Purchase Of Investment | N/A | N/A | -71,813 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 42,781 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -1,122 | 0 | 63 |
| Investing Cash Flow | $-102,185 | $-1,370,646 | $-995,048 | $-227,720 | $-36,135 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,693,512 | 656,190 | 1,241,027 | 286,966 | 143,598 |
| Debt Repayment | -1,622,749 | -4,000 | -299,000 | N/A | -64,844 |
| Common Stock Issued | 11,038 | 10,423 | 503,478 | 42,828 | 6,637 |
| Common Stock Repurchased | -992 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -26,533 | -5,539 | -3,024 | 8,491 | -18,675 |
| Financing Cash Flow | $54,276 | $657,074 | $1,442,481 | $338,285 | $66,716 |
| Exchange Rate Effect | 5,316 | -1,210 | -790 | 213 | 99 |
| Beginning Cash Position | 516,150 | 861,476 | 218,807 | 80,480 | 104,087 |
| End Cash Position | 757,897 | 516,150 | 859,616 | 218,807 | 80,480 |
| Net Cash Flow | $241,747 | $-345,326 | $640,809 | $138,327 | $-23,607 |
| Free Cash Flow | |||||
| Operating Cash Flow | 284,340 | 369,456 | 194,166 | 27,549 | -54,287 |
| Capital Expenditure | -4,336 | -15,725 | -7,156 | -3,500 | -1,198 |
| Free Cash Flow | 280,004 | 353,731 | 187,010 | 24,049 | -55,485 |